Viewing Study NCT05560334


Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2025-12-26 @ 5:01 PM
Study NCT ID: NCT05560334
Status: UNKNOWN
Last Update Posted: 2022-09-29
First Post: 2022-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module